Elżbieta Marczyk

Pathologic complete response to neoadjuvant cisplatin in BRCA1-positive breast cancer patients

Tomasz Byrski, Tomasz Huzarski, R. Dent et al. · Breast Cancer Research and Treatment · 2014 · 269 citations

Medicine, Oncology, Pharmacology +14

Results of a phase II open-label, non-randomized trial of cisplatin chemotherapy in patients with BRCA1-positive metastatic breast cancer

Tomasz Byrski, Rebecca Dent, Paweł Blecharz et al. · Breast Cancer Research · 2012 · 213 citations · Full text

Medicine, Oncology, Pharmacology +13

Ten-Year Survival in Patients With <i>BRCA1</i>-Negative and <i>BRCA1</i>-Positive Breast Cancer

Tomasz Huzarski, Tomasz Byrski, Jacek Gronwald et al. · Journal of Clinical Oncology · 2013 · 161 citations

Medicine, Biostatistics, Oncology +15

Breast cancer predisposing alleles in Poland

Bohdan Górski, Cezary Cybulski, Tomasz Huzarski et al. · Breast Cancer Research and Treatment · 2005 · 126 citations

Life Sciences, Genetics, Oncology +12

Recurrent mutations of BRCA1, BRCA2 and PALB2 in the population of breast and ovarian cancer patients in Southern Poland

Piotr Wójcik, Marek Jasiówka, E. Strycharz et al. · Hereditary Cancer in Clinical Practice · 2016 · 44 citations · Full text

Life Sciences, Genetics, Molecular Genetics +16